MedPath

Effect of platelet rich plasma (PRP) improving pregnancy outcome

Phase 2
Conditions
oninflammatory disorders of female genital tract.
Registration Number
IRCT20160722029027N9
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

Women under 40 years
30>BMI
At least two pregnancy loss

Exclusion Criteria

Immunologic disorder
Anti phospholipid syndrome
Hormonal disturbance
Chromosomal disorder
Congenital and acquired uterine disorder
Hematological disturbance

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 5-7 weeks of gestation. Method of measurement: Ultrasonography.;Ongoing pregnancy. Timepoint: 20 weeks of gestation. Method of measurement: Ultrasonography.;Live birth. Timepoint: 9 months after embryo transfer. Method of measurement: Visualization.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath